0001213900-24-074517.txt : 20240830 0001213900-24-074517.hdr.sgml : 20240830 20240830160512 ACCESSION NUMBER: 0001213900-24-074517 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240812 FILED AS OF DATE: 20240830 DATE AS OF CHANGE: 20240830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Czuczman Myron CENTRAL INDEX KEY: 0001817716 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41534 FILM NUMBER: 241269855 MAIL ADDRESS: STREET 1: C/O CITIUS PHARMACEUTICALS, INC. STREET 2: 11 COMMERCE DRIVE, 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CITIUS ONCOLOGY, INC. CENTRAL INDEX KEY: 0001851484 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 BUSINESS PHONE: (908) 967-6677 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVE, STREET 2: SUITE 2446 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: TenX Keane Acquisition DATE OF NAME CHANGE: 20210315 4/A 1 ownership.xml X0508 4/A 2024-08-12 2024-08-14 0 0001851484 CITIUS ONCOLOGY, INC. CTOR 0001817716 Czuczman Myron C/O CITIUS ONCOLOGY, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016 0 1 0 0 Chief Medical Officer 0 Stock Option (Right to Buy) 2.15 2024-08-12 4 A 0 1400000 0 A 2033-07-05 Common Stock 1400000 1400000 D This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024. This Form 4 has been amended to correct the amount of option shares held by the Reporting Person. /s/ Lorna A. Knick, by Power of Attorney 2024-08-30